Second Additional Financing for the Mauritania COVID-19 Strategic Preparedness and Response Project (SPRP) (WB-P178100)

Countries
  • Mauritania
Geographic location where the impacts of the investment may be experienced.
Financial Institutions
  • World Bank (WB)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Approved
Stage of the project cycle. Stages vary by development bank and can include: pending, approval, implementation, and closed or completed.
Bank Risk Rating
A
Environmental and social categorization assessed by the development bank as a measure of the planned project’s environmental and social impacts. A higher risk rating may require more due diligence to limit or avoid harm to people and the environment. For example, "A" or "B" are risk categories where "A" represents the highest amount of risk. Results will include projects that specifically recorded a rating, all other projects are marked ‘U’ for "Undisclosed."
Voting Date
Dec 23, 2021
Date when project documentation and funding is reviewed by the Board for consideration and approval. Some development banks will state a "board date" or "decision date." When funding approval is obtained, the legal documents are accepted and signed, the implementation phase begins.
Borrower
Government of Mauritania
A public entity (government or state-owned) provided with funds or financial support to manage and/or implement a project.
Sectors
  • Education and Health
  • Law and Government
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
Loan
The categories of the bank investment: loan, grant, guarantee, technical assistance, advisory services, equity and fund.
Investment Amount (USD)
$ 20.00 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Project Cost (USD)
$ 20.00 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Bank Documents
Other Related Projects
Primary Source

Original disclosure @ WB website

Updated in EWS Feb 24, 2022

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description
If provided by the financial institution, the Early Warning System Team writes a short summary describing the purported development objective of the project and project components. Review the complete project documentation for a detailed description.

According to bank documents, the project objective is to strengthen the national public health preparedness capacity to prevent, detect and respond to the COVID-19 pandemic in Mauritania.

Vaccine purchasing will be done through Component 1 of the Global COVID-19 MPA.

  1. Through Component 1, the proposed second AF will also continue to support the strengthening of the health system to prevent, detect, and treat COVID-19 cases.

    1. Subcomponent 1.1: Case Detection, Confirmation, Contact Tracing, Recording, Reporting (parent project: US$1.2 million, AF1: US$0.5 million, AF2: US$2.2 million). This subcomponent will continue to support strengthening of climate-sensitive disease surveillance systems and build testing capacity for early detection and confirmation of COVID-19 cases. This support will also complement activities already funded through the REDISSE III Project (P161163) to strengthen the national laboratory system.

    2. Subcomponent 1.2: Health System Strengthening (Parent Project: US$2.2 million; AF1: US$2.5 million, AF2: US$2.3 million). This subcomponent will continue to support health system strengthening to provide optimal medical care, maintain essential community services, minimize risks for patients and health personnel, including training health facilities staff and frontline workers on risk mitigation measures and providing them with the appropriate protective equipment and hygiene materials, and purchasing energy-efficient equipment.

    3. Subcomponent 1.3: Communication Preparedness (Parent Project: US$0.8 million; AF1: US$0.7 million; AF2: US$1.8 million). The proposed second AF will continue to support risk communication activities and community engagement to raise awareness, knowledge, and understanding among the general population about the risk and potential impact of the pandemic, as well as the compounded risk of climate change on the population, and to address vaccine hesitancy.

    4. Subcomponent 1.4: COVID-19 Vaccine Purchase and Deployment (Parent Project: US$0.00 million; AF1: US$10.03 million; AF2: US$9.8 million). This sub-component will continue to finance vaccine acquisition and deployment; US$5.2 million for vaccine acquisition via AVATT for J&J vaccines and US$4.6 million for vaccine deployment.

  2. The proposed AF, through Component 2 (parent project: US$1.0 million; AF1: US$1.0 million; AF2: US$3.9 million), will continue to support the implementation actors at central and local levels regarding coordination, financial management (FM), procurement, and the development of project monitoring and the evaluation.

    1. To ensure successful implementation of the project, the second proposed AF through Subcomponent 2.1: Implementation Management (parent project: US$0.8 million; AF1:US$0.3 million; AF2:US$0.5 million) will continue to support costs associated with project implementation.

    2. On project M&E activities, the second proposed AF will continue to finance Subcomponent 2.2: Project M&E (parent project:US$0.2 million; AF1:US$0.2 million; AF2:US$0.5 million) to support the strengthening of existing data and monitoring systems to accommodate COVID-19 vaccines.

    3. Activities under Subcomponent 2.3: COVID-19 Vaccine Planning and Management (parent project: US$0.0 million; AF1: US$0.5 million; AF2:US$2.9 million) will continue to be supported particularly as it relates to pharmacovigilance and the management of AEFIs. The second AF will continue to support the target population groups as summarized in Error! Reference source not found. below, but it is important to note that the country has opened eligibility to populations 18 years and over.

Investment Description
Here you can find a list of individual development financial institutions that finance the project.

Contact Information
This section aims to support the local communities and local CSO to get to know which stakeholders are involved in a project with their roles and responsibilities. If available, there may be a complaint office for the respective bank which operates independently to receive and determine violations in policy and practice. Independent Accountability Mechanisms receive and respond to complaints. Most Independent Accountability Mechanisms offer two functions for addressing complaints: dispute resolution and compliance review.

World Bank:
Fatoumata Binta Maama Barry
Health Specialist

Mohamed Vadel Taleb El Hassen
Senior Economist, Health

Borrower:
Islamic Republic of Mauritania
Abdel Aziz Ould Dahi
Minister of Economy and Industry
aadahi@economie.gov.mr

Implementing Agency:
Ministry of Health
Dr. Sidi Ould Zahaf
Minister of Health
sozahaf@sante.gov.mr 

ACCESS TO INFORMATION

To submit an information request for project information, you will have to create an account to access the Access to Information request form. You can learn more about this process at: https://www.worldbank.org/en/access-to-information/request-submission 

ACCOUNTABILITY MECHANISM OF THE WORLD BANK

The World Bank Inspection Panel is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by a World Bank-financed project. If you submit a complaint to the Inspection Panel, they may investigate to assess whether the World Bank is following its own policies and procedures for preventing harm to people or the environment. You can contact the Inspection Panel or submit a complaint by emailing ipanel@worldbank.org. Information on how to file a complaint and a complaint request form are available at: https://www.inspectionpanel.org/how-to-file-complaint 

How it works

How it works